![James D. Woodward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James D. Woodward
Plus aucun poste en cours
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
John Koerner | M | 81 |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | - |
Chris W. Hegele | M | - |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | - |
Ronald S. Hill | M | - |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | - |
Richard C. Klann | M | - |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | 11 ans |
Jeffrey L. Blumer | M | - |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | - |
Teodoro Forcht-Dagi | M | 75 |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | - |
Francis V. Lamberti | M | - |
Encelle, Inc.
![]() Encelle, Inc. Medical SpecialtiesHealth Technology Encelle, Inc. engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes. Its patented tissue regeneration technology has applications for therapeutic indications including dermal healing, bone repair, connective tissue repair and soft tissue augmentation. The company is headquartered in Raleigh, NC | 8 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 7 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- James D. Woodward
- Réseau Personnel